GlassScriptPhysician profile
Crystal Pouncil
NPI 1336673011
$3,895.33
in general payments reported to CMS, 2019-2025
38 companies · $977 in 2025
The $977 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $511 · 2022: $657 · 2023: $616 · 2024: $1,135 · 2025: $977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,727.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $688.37 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $410.05 | 2021-2025 | |
| Abbvie INC. | $284.21 | 2021-2025 | |
| Glaxosmithkline, LLC. | $269.60 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $245.87 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $207.77 | 2021-2025 | Jardiance, Synjardy, Ofev |
| Corium, LLC | $197.85 | 2022-2025 | Azstarys, Azstarys |
| Astrazeneca Pharmaceuticals LP | $182.99 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Exact Sciences Corporation | $128.17 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.89 | 2022-2025 | Xifaxan, Trulance |
| Boston Scientific Corporation | $105.49 | 2022-2024 | |
| Dexcom, INC. | $98.94 | 2021-2025 | Dexcom G6 Transmitter |
| Welch Allyn | $88.41 | 2021 | |
| Amarin Pharma, INC. | $79.53 | 2021-2023 | |
| Corcept Therapeutics | $70.33 | 2024-2025 | Korlym |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $69.94 | 2025 | Yupelri |
| Astellas Pharma US INC | $60.14 | 2021-2025 | Veozah |
| Amgen INC. | $55.50 | 2022-2024 | Otezla, Repatha |
| Baxter Healthcare | $53.04 | 2022 | |
| Azurity Pharmaceuticals, INC. | $51.12 | 2024-2025 | Horizant |
| Phathom Pharmaceuticals, INC. | $49.38 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $46.06 | 2022 | |
| Pfizer INC. | $39.94 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $32.72 | 2023-2024 | Gardasil 9, Gardasil, Capvaxive |
| Eisai INC. | $32.23 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.75 | 2022 | |
| Abbott Laboratories | $26.48 | 2025 | Freestyle Libre 3 |
| Renalytix Ai, INC. | $21.35 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Ethicon US, LLC | $18.96 | 2022 | |
| Esperion Therapeutics, INC. | $17.94 | 2023 | Nexletol |
| Genentech USA, INC. | $17.88 | 2021 | |
| Nevro Corp. | $17.14 | 2024 | Senza |
| Currax Pharmaceuticals LLC | $16.32 | 2023 | Nexlizet, Contrave, Nexletol |
| Philips North America LLC | $14.36 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $14.28 | 2021 | |
| Axsome Therapeutics, INC. | $14.05 | 2025 | Symbravo |
| Edwards Lifesciences Corporation | $13.98 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Sanofi-Aventis U.S. LLC | $12.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Pouncil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.